Examination of CD302 as a potential therapeutic target for acute myeloid leukemia

Acute myeloid leukemia (AML) is the most common form of adult acute leukemia with ~20,000 new cases yearly. The disease develops in people of all ages, but is more prominent in the elderly, who due to limited treatment options, have poor overall survival rates. Monoclonal antibodies (mAb) targeting...

Descripción completa

Detalles Bibliográficos
Autores principales: Lo, Tsun-Ho, Abadir, Edward, Gasiorowski, Robin E., Kabani, Karieshma, Ramesh, Murari, Orellana, Daniel, Fromm, Phillip D., Kupresanin, Fiona, Newman, Elizabeth, Cunningham, Ilona, Hart, Derek N. J., Silveira, Pablo A., Clark, Georgina J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510432/
https://www.ncbi.nlm.nih.gov/pubmed/31075107
http://dx.doi.org/10.1371/journal.pone.0216368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510432/
https://www.ncbi.nlm.nih.gov/pubmed/31075107
http://dx.doi.org/10.1371/journal.pone.0216368

Ejemplares similares